Vine Hill Capital Investment Corp. II VHCP Proceeds From Sale Of Private Placement Warrants

Proceeds From Sale Of Private Placement Warrants at other companies

Quantum Computing Inc.QUBT

$1K-99.8%

Aura Biosciences, Inc.AURA

$3.54M—

XER

Xeris Biopharma Holdings, Inc.XERS

$7.33M—

Taysha Gene Therapies, Inc.TSHA

$56.25K—

Viridian Therapeutics, Inc.VRDN

$0-100%

Opus GeneticsIRD

$0-100%

Operating income-$437.0K—

Net income$1.6M—

EPS (diluted)$0.05—

Cash & equivalents$2.0M—

Total equity-$5.8M—

Total assets$234.9M—

Operating cash flow-$501.0K—

Market cap$306.05M+0.3%

Current ratio8.6×—

Reported directly by Vine Hill Capital Investment Corp. II in its filing.

Tagged under the XBRL concept vhcpu:ProceedsFromSaleOfPrivatePlacementWarrants.

The official record: Vine Hill Capital Investment Corp. II ’s 10-K, filed March 30, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Vine Hill Capital Investment Corp. II 's proceeds from sale of private placement warrants?: Vine Hill Capital Investment Corp. II (VHCP) reported proceeds from sale of private placement warrants of $5.5M in Q4 2025.
What does proceeds from sale of private placement warrants mean?: Represents cash proceeds received from the issuance of warrants to private investors, typically as part of a capital raise. This metric highlights the company's ability to attract private capital and the potential future dilution associated with these instruments.